TScan Therapeutics, Inc.TCRXNASDAQ
Loading
Price-to-earnings ratio
Latest
-1.00
↑ 82% vs avg
Percentile
P83
Within normal range
Streak
2 yr
Consecutive growthElevated
Average
-5.70
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -1.00 | +62.5% |
| 2024 | -2.67 | +37.7% |
| 2023 | -4.29 | -661.6% |
| 2022 | -0.56 | +74.6% |
| 2021 | -2.21 | +77.9% |
| 2020 | -10.02 | +47.7% |
| 2019 | -19.17 | - |